Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells-Reference-Cited by-同舟云学术

Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells

Published:2020 Issue:6 Volume:1 Page:1775-1787
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Comparetti Edson J.¹²³⁴⁵^ORCID,Lins Paula M. P.¹²³⁴⁵^ORCID,Quitiba João V. B.¹²³⁴⁵,Zucolotto Valtencir¹²³⁴⁵^ORCID

Affiliation:

1. Nanomedicine and Nanotoxicology Group

2. Physics Institute of São Carlos

3. University of São Paulo

4. São Carlos

5. Brazil

Abstract

Human pancreatic carcinoma is among the neoplasias with the highest number of deaths, and the frequency of relapses has demanded novel therapeutic intervention.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2020/MA/D0MA00367K

Reference41 articles.

1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries